{
  "zip": "111 53",
  "sector": "Healthcare",
  "fullTimeEmployees": 232,
  "longBusinessSummary": "Oncopeptides AB (publ), a pharmaceutical company, develops pharmaceuticals drugs for the treatment of cancer. Its lead product candidate is melflufen, a novel peptide conjugated alkylator for the treatment of hematological cancer multiple myeloma. The company was founded in 2000 and is headquartered in Stockholm, Sweden.",
  "city": "Stockholm",
  "phone": "46 86 15 20 40",
  "country": "Sweden",
  "companyOfficers": [],
  "website": "http://www.oncopeptides.se",
  "maxAge": 1,
  "address1": "Vastra Tradgardsgatan 15",
  "industry": "Biotechnology",
  "previousClose": 20.38,
  "regularMarketOpen": 20.38,
  "twoHundredDayAverage": null,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 20.38,
  "navPrice": null,
  "averageDailyVolume10Day": null,
  "totalAssets": null,
  "regularMarketPreviousClose": 20.38,
  "fiftyDayAverage": null,
  "trailingAnnualDividendRate": null,
  "open": 20.38,
  "averageVolume10days": null,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 0.31439,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 20.38,
  "priceHint": 2,
  "currency": "USD",
  "regularMarketVolume": 258,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 1357719680,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": null,
  "priceToSalesTrailing12Months": null,
  "dayLow": 20.38,
  "ask": null,
  "ytdReturn": null,
  "askSize": null,
  "volume": 258,
  "fiftyTwoWeekHigh": 20.38,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 20.38,
  "bid": null,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": null,
  "dayHigh": 20.38,
  "exchange": "PNK",
  "shortName": "ONCOPEPTIDES AB",
  "longName": "Oncopeptides AB (publ)",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "ONPPF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_12930666",
  "uuid": "248ea7fe-467d-3241-9c4a-4f87dc40bf05",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 0,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": null,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0.69211,
  "netIncomeToCommon": null,
  "trailingEps": null,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.04859,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 47628558,
  "enterpriseValue": 1381166464,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 20.38,
  "logo_url": "https://logo.clearbit.com/oncopeptides.se"
}